15064320|t|Compound heterozygous mutations in the SRD5A2 gene exon 4 in a male pseudohermaphrodite patient of Chinese origin.
15064320|a|The goal of this study was to perform 5-alpha-reductase type 2 gene (SRD5A2) analysis in a male pseudohermaphrodite (MPH) patient with normal testosterone (T) production and normal androgen receptor (AR) gene coding sequences. A patient of Chinese origin with ambiguous genitalia at 14 months, a 46,XY karyotype, and normal T secretion under human chorionic gonadotropin (hCG) stimulation underwent a gonadectomy at 20 months. Exons 1-8 of the AR gene and exons 1-5 of the SRD5A2 gene were sequenced from peripheral blood DNA. AR gene coding sequences were normal. SRD5A2 gene analysis revealed 2 consecutive mutations in exon 4, each located in a different allele: 1) a T nucleotide deletion, which predicts a frameshift mutation from codon 219, and 2) a missense mutation at codon 227, where the substitution of guanine (CGA) by adenine (CAA) predicts a glutamine replacement of arginine (R227Q). Testes located in the inguinal canal showed a normal morphology for age. The patient was a compound heterozygote for SRD5A2 mutations, carrying 2 mutations in exon 4. The patient showed an R227Q mutation that has been described in an Asian population and MPH patients, along with a novel frameshift mutation, Tdel219. Testis morphology showed that, during early infancy, the 5-alpha-reductase enzyme deficiency may not have affected interstitial or tubular development.
15064320	39	45	SRD5A2	GeneOrGeneProduct	6716
15064320	63	87	male pseudohermaphrodite	DiseaseOrPhenotypicFeature	D058490
15064320	88	95	patient	OrganismTaxon	9606
15064320	153	177	5-alpha-reductase type 2	GeneOrGeneProduct	6716
15064320	184	190	SRD5A2	GeneOrGeneProduct	6716
15064320	206	230	male pseudohermaphrodite	DiseaseOrPhenotypicFeature	D058490
15064320	232	235	MPH	DiseaseOrPhenotypicFeature	D058490
15064320	237	244	patient	OrganismTaxon	9606
15064320	257	269	testosterone	ChemicalEntity	D013739
15064320	271	272	T	ChemicalEntity	D013739
15064320	296	313	androgen receptor	GeneOrGeneProduct	367
15064320	315	317	AR	GeneOrGeneProduct	367
15064320	344	351	patient	OrganismTaxon	9606
15064320	439	440	T	ChemicalEntity	D013739
15064320	457	485	human chorionic gonadotropin	ChemicalEntity	D006063
15064320	487	490	hCG	ChemicalEntity	D006063
15064320	559	561	AR	GeneOrGeneProduct	367
15064320	588	594	SRD5A2	GeneOrGeneProduct	6716
15064320	642	644	AR	GeneOrGeneProduct	367
15064320	680	686	SRD5A2	GeneOrGeneProduct	6716
15064320	786	860	T nucleotide deletion, which predicts a frameshift mutation from codon 219	SequenceVariant	c|DEL|CODON219|T
15064320	929	959	guanine (CGA) by adenine (CAA)	SequenceVariant	rs9332964
15064320	971	1004	glutamine replacement of arginine	SequenceVariant	rs9332964
15064320	1006	1011	R227Q	SequenceVariant	rs9332964
15064320	1091	1098	patient	OrganismTaxon	9606
15064320	1131	1137	SRD5A2	GeneOrGeneProduct	6716
15064320	1185	1192	patient	OrganismTaxon	9606
15064320	1203	1208	R227Q	SequenceVariant	rs9332964
15064320	1269	1272	MPH	DiseaseOrPhenotypicFeature	D058490
15064320	1273	1281	patients	OrganismTaxon	9606
15064320	1323	1330	Tdel219	SequenceVariant	c|DEL|CODON219|T
15064320	1389	1406	5-alpha-reductase	GeneOrGeneProduct	6716
15064320	Association	D013739	D006063	No
15064320	Association	c|DEL|CODON219|T	D058490	Novel
15064320	Association	rs9332964	D058490	Novel
15064320	Association	6716	D058490	Novel